Up­start maps plans to build fi­bro­sis pipeline; FDA ex­tends re­view pe­ri­od for Lil­ly’s baric­i­tinib

• A group of aca­d­e­m­ic in­ves­ti­ga­tors in Toron­to, work­ing through MaRS In­no­va­tion, are spin­ning out new tech to launch a biotech start­up dubbed Fi­bro­cor …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.